Generated $193 million in constant currency in the third quarter; strategic initiatives and SKU rationalization impacted revenue by $13 millionTilray...
Results
March 31, 2025 4:00 PM EDT | Source: Phio Pharmaceuticals Corp. Continues advancing clinical trial for INSTASYL siRNA lead...
CAPE CANAVERAL, Fla., March 31, 2025--(BUSINESS WIRE)--Sidus Space (NASDAQ: SIDU) (the "Company" or "Sidus"), an innovative, agile space mission enabler,...
– Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension (OLE) trial...
Sold approximately 120,000 Nu.Q® Vet Cancer Tests in 2024. Expanded access to the Nu.Q® Vet Cancer Test – now available for...
I find applying makeup—the methodical swiping of a soft eyeshadow brush, calming tapping of my finger dipped in the best...
